Mind the gap: management of benign prostatic obstruction (BPO) surgical candidates on antithrombotics

Autore

Dimitropoulos K., Gravas S.

Data

2020

Language

en

DOI

10.1007/s00345-018-02625-2

Soggetto

anticoagulant agent

fibrinolytic agent

prostate hypertrophy

Fibrinolytic Agents

Prostatic Hyperplasia

Mostra tutti i dati dell'item

Abstract

[No abstract available]

URI

http://hdl.handle.net/11615/73341

Collections

Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]